Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice
Open Access
- 1 October 2000
- journal article
- Published by American Society of Hematology in Blood
- Vol. 96 (7) , 2520-2527
Abstract
The pathogenic effects of antiplatelet antibodies were investigated in mice. Monoclonal antibodies (mAbs) of different immunoglobulin G subclass directed against mouse GPIIbIIIa, GPIIIa, GPIbα, GPIb-IX, GPV, and CD31 were generated and characterized biochemically. MAbs against GPIb-IX, GPV, CD31, and linear epitopes on GPIIIa had mild and transient effects on platelet counts and induced no spontaneous bleeding. Anti-GPIbα mAbs induced profound irreversible thrombocytopenia (< 3% of normal) by Fc-independent mechanisms but only had minor effects on hematocrits. In contrast, injection of intact mAbs, but not F(ab)2 fragments, against conformational epitopes on GPIIbIIIa, induced irreversible thrombocytopenia, acute systemic reactions, hypothermia, decreased hematocrits, and a paradoxical loss of surface GPIIbIIIa on platelets in vivo, the latter suggesting the formation of platelet-derived microparticles. Blockage of platelet-activating factor receptors inhibited the acute reactions, but not thrombocytopenia, loss of GPIIbIIIa, and decreases in hematocrits. Repeated injections of low doses of anti-GPIIbIIIa antibodies resulted in profound thrombocytopenia and bleeding, whereas no acute systemic reactions were observed. These data strongly suggest that the identity of the target antigen recognized by antiplatelet antibodies determines the mechanisms of platelet destruction and the severity of bleeding in mice, the latter depending on previously unrecognized anti-GPIIbIIIa-specific inflammatory mechanisms.Keywords
This publication has 26 references indexed in Scilit:
- Management of Chronic Autoimmune Thrombocytpenic Purpura (ITP) in AdultsTransfusion Science, 1998
- Platelet Autoantibodies in Immune Thrombocytopenic PurpuraTransfusion Science, 1998
- Autoimmune thrombocytopenic purpura (AITP) and acquired thrombasthenia due to autoantibodies to GP IIb–IIIa in a patient with an unusual platelet membrane glycoprotein compositionAmerican Journal of Hematology, 1998
- Fc receptorsCurrent Opinion in Immunology, 1997
- Impaired IgG-Dependent Anaphylaxis and Arthus Reaction in FcγRIII (CD16) Deficient MiceImmunity, 1996
- Reactivity of autoantibodies from chronic ITP patients with recombinant glycoprotein Ilia peptidesBritish Journal of Haematology, 1995
- Carboxypeptidase M Is Identical to the MAX.1 Antigen and Its Expression Is Associated with Monocyte to Macrophage DifferentiationJournal of Biological Chemistry, 1995
- Functional studies on platelets of a patient with an acquired disorder of platelet function associated with autoantibodies against membrane glycoprotein IIb/IIIa complexThrombosis Research, 1993
- Failure of the platelet-activating-factor antagonist WEB 2086 BS for treatment of chronic autoimmune thrombocytopeniaAnnals of Hematology, 1990
- Autoantibody against platelet glycoprotein II b/ III a in a patient with non-Hodgkin's lymphomaThrombosis Research, 1989